United Therapeutics Reports Third Quarter 2026 Financial Results
FROM THE WIRE · BUSINESSWIRE.COM
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2026. Total revenues in the third quarter of 2026 increased…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralQuarterly results show ordinary growth with no guidance change that would clearly move the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Total revenues in the third quarter of 2026 rose 4% year-over-year to $832.5 million.
- 02Revenues in the third quarter of 2025 were $799.5 million.
- 03The company says it is advancing a portfolio of new therapies.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets